Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive
[ClickPress, Wed Apr 17 2019] Drug eluting balloons (DEB), one of the newest medical devices, have become popular as it is used for treating coronary artery diseases. In addition, patients who find difficult to undergo percutaneous coronary intervention (PCI) procedures opt for drug eluting balloon catheter. Consequently, drug eluting balloon catheter manufacturers have upped their production capacity. In a bid to expand its market penetration, companies vie to manufacture cost-effective catheters. Rising cases of cardiology intervention and rampant cardiovascular diseases have further signified the importance of drug eluting balloon catheter.
The emergence of new-generation drug eluting balloon catheters have opened avenue for stakeholders and manufacturers in the market. Moreover, in order to accentuate its utility, massive investments in research and development pipelines have been witnessed. Growing number of companies are gradually shifting towards manufacturing drug eluting balloon catheters as it has turned out be viable and efficient vis-à-vis balloon angioplasty or stenting.
Request Sample Here:
A lately compiled research analysis on the drug eluting balloon catheter market unveil that ever-increasing healthcare expenditure, burgeoning geriatric demographic, enhanced reimbursement support by governments will account for the augmentation of the drug eluting balloon catheter.
However, DEB do face daunting challenge rom drug eluting stents (DES) for the treatment of coronary artery disease. Though clinical application of drug eluting stents has significantly lessened the incidence of in-stent restenosis, delayed stent thrombosis and malapposition does not augur fare well with DES. On account of complications associated with DES, drug eluting balloon catheter was designed to negate insertion of a permanent foreign object in the blood vessel.
By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.
By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.
Drug Eluting Balloon Catheter Market: Overview
The report provides an exhaustive analysis on the market for drug eluting balloon catheter for the assessment period 2018-2026. The report further sheds light on the dynamics of the drug eluting balloon catheter market which significantly impact the growth of the market.
Furthermore, the report delves into the segregation of the market which is will provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.
Browse Full Report with TOC:
The report also focuses on the epidemiology and product mapping behavior on the basis of region. The report also incorporates average pricing analysis and sheds light on supply chain. Assessment of the drug eluting balloon catheter market incorporates provision of relevant market numbers and regional assessment of major factors. The report also includes regional and country-wise assessment.
A robust research methodology has been adopted for the forecast and assessment on the drug eluting balloon catheter market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The market size of the drug eluting balloon catheter is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.
Drug Eluting Balloon Catheter Market: Competitive Landscape
Prominent market players being instrumental in the growth of the drug eluting balloon catheter market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis as well as gives insights on drug eluting balloon catheter market indication list and the drug eluting balloon catheter market indication sales data and key financials.
Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.
Analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the drug eluting balloon catheter market.
For More Information Raise Enquiry:
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852